Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Operating activities
Net income	$ 130	$ 114	$ 62
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	90	100	116
Stock-based compensation expense	112	119	126
Deferred income taxes	31	(11)	(11)
Loss on Blue Chip Swap	1	4	13
Changes in assets and liabilities:
Receivables	(17)	52	78
Inventories	5	(5)	(5)
Account payables and accrued expenses	(48)	(1)	7
Deferred revenue	22	(70)	(5)
Other assets and liabilities	(21)	1	(6)
Net cash provided by operating activities	305	303	375
Investing activities
Expenditures for property and equipment	(19)	(24)	(19)
Additions to capitalized software	(1)	(2)	(1)
Business acquisitions, other investing activities and proceeds on Blue Chip Swap, net of purchases	(1)	(6)	(29)
Net cash used in investing activities	(21)	(32)	(49)
Financing activities
Repurchases of common stock	(140)	(215)	(308)
Repayments of long-term borrowings	(25)	(19)	0
Payments of finance leases	(69)	(71)	(82)
Other financing activities, net	1	(1)	7
Net cash used in financing activities	(233)	(306)	(383)
Effect of exchange rate changes on cash and cash equivalents	22	(30)	(28)
Increase (decrease) in cash, cash equivalents and restricted cash	73	(65)	(85)
Cash, cash equivalents and restricted cash at beginning of year	421	486	571
Cash, cash equivalents and restricted cash at end of year	494	421	486
Reconciliation of cash, cash equivalents and restricted cash to the Consolidated Balance Sheets
Cash and cash equivalents	493	420	486
Restricted cash	1	1	0
Total cash, cash equivalents and restricted cash	494	421	486
Supplemental cash flow disclosure:
Assets acquired by finance lease	77	29	90
Assets acquired by operating lease	2	5	6
Cash paid during the year for:
Income taxes, net	71	75	65
Interest	$ 26	$ 29	$ 30